Optimizing the Use of Sunitinib in Metastatic Renal Cell Carcinoma: An Update From Clinical Practice

Author： Schmidinger Manuela Arnold Dirk Szczylik Cezary Wagstaff John Ravaud Alain

ISSN： 0735-7907

Source： Cancer Investigation, Vol.28, Iss.8, 2010-09, pp. : 856-864

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib for metastatic renal cell carcinoma

By Mukherji Deborah Larkin James Pickering Lisa

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1377-1385

Future Medicine

Access to resources Recommend Favorite

Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient

By Medioni Jacques Cojocarasu Oana Banu Eugeniu Cassar-Queudeville Alexia Halimi Philippe Oudard Stéphane

Targeted Oncology, Vol. 2, Iss. 3, 2007-07 ,pp. : 193-195

Springer Publishing Company

Access to resources Recommend Favorite

Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma

By Bono Petri Rautiola Juhana Utriainen Tapio Joensuu Heikki

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 569-573

Informa Healthcare

Access to resources Recommend Favorite

Sunitinib adverse events in metastatic renal cell carcinoma: a meta-analysis

By Ibrahim Ezzeldin Kazkaz Ghieth Abouelkhair Khaled Bayer Ali Elmasri Osama

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1060-1069

Springer Publishing Company

Access to resources Recommend Favorite

Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study

By Paglino Chiara Imarisio Ilaria Ganini Carlo Morbini Patrizia Vercelli Alessandro Bregant Cristina Porta Camillo

Future Oncology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1605-1612

Future Medicine

Access to resources Recommend Favorite